RiverFront Investment Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1469751 RICHMOND, VA

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$39,542,811

+$11,086,047 QoQ

Shares Held

32,968

+6.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.93%

of 13F equity value

Holder Rank

#611

of 4,605 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RiverFront Investment Group, LLC holds $89,602,289 across 9 Drug Manufacturers - General names. LLY ranks #1 (44.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	32,968	$39,542,811
2	JNJ	Johnson & Johnson	64,265	$16,321,382
3	ABBV	AbbVie Inc.	59,624	$15,003,783
4	MRK	Merck & Co., Inc.	77,843	$10,002,825
5	AMGN	Amgen Inc	13,012	$4,711,905
6	BMY	Bristol Myers Squibb Co	32,862	$1,893,508
7	PFE	Pfizer Inc	45,974	$1,107,053
8	GILD	Gilead Sciences, Inc.	5,103	$644,713

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$39,542,811	32,968	+6.6%	Shares	Sole	2026-07-29
2026-03-31	$28,456,764	30,939	+6.3%	Shares	Sole	2026-05-11
2025-12-31	$31,278,564	29,105	+23.2%	Shares	Sole	2026-02-05
2025-09-30	$18,029,690	23,630	+36.0%	Shares	Sole	2025-11-13
2025-06-30	$13,542,774	17,373	+85.0%	Shares	Sole	2025-08-12
2025-03-31	$7,756,120	9,391	+82.1%	Shares	Sole	2025-05-14
2024-12-31	$3,980,432	5,156	+99.3%	Shares	Sole	2025-02-12
2024-09-30	$2,291,926	2,587	+814.1%	Shares	Sole	2024-11-08
2024-06-30	$256,222	283	-79.7%	Shares	Sole	2024-08-28
2021-06-30	$320,639	1,397	+20.6%	Shares	Sole	2021-08-09
2021-03-31	$216,337	1,158	-20.1%	Shares	Sole	2021-04-29
2020-12-31	$244,818	1,450	—	Shares	Sole	2021-02-03
No filing history on record for this holder in this stock.